ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Galderma Group AG clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 297 studies whose lead sponsor is Galderma Group AG or one of 4 companies grouped under it. 12 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 3, 2026.

Our grouping of 4 registry names, not the registry’s. See them and correct one ↓

Compare Galderma Group with 3SBio and Sanofi →

Pipeline: 3 programs

Each counted once: 3 with a study Galderma Group AG leads registered in the last two years.

  • Phase 3
  • Phase 4 (approved, new studies)

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Galderma Group AG’s own registered studies; Galderma Group AG’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Galderma Group AG’s studies test, most open studies first — 27 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 17 more

Coming up

8 of Galderma Group AG’s studies under way reach primary completion within a year, 2 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 1N’26
  2. 2D
  3. J’27
  4. F
  5. M
  6. A
  7. 1M
  8. J
  9. J
  10. A
  11. 1S
  12. 1O
  13. 2N

Add all 8 to your calendar (.ics) → With an account.

All 297 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now124%Recruiting 11 · Not yet recruiting 1
  • Under way, not recruiting62%
  • Completed26991%
  • Stopped early93%Terminated 5 · Withdrawn 4
  • Status unknown or other1<1%

Phase

  • Phase 477
  • Phase 371
  • Phase 235
  • Phase 17

Where

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 2112
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 826

By the year each study started; 24 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Galderma Group AG.

  • Galderma R&D
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    284 studies →
  • Galderma Brasil Ltda.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    6 studies →
  • Galderma Laboratorium GmbH
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    4 studies →
  • CollaGenex Pharmaceuticals
    Acquired — became part of Galderma Group AG, Apr 7, 2008 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →

Focus areas

Conditions Galderma Group AG leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 297. Browse all 297 →